| Literature DB >> 36134116 |
Peng Chen1, Xuan Cui2, Xi Chen3, Zhengyu Chen1, Xia Zhang1, Chengrong Zhang1, Jinyu Zhang1.
Abstract
In order to investigate the effects of different doses of Dahuang Zhechong pills on the ubiquitin proteasome pathway/nuclear factor-κB (UPP-NF-κB) in rats with atherosclerosis (AS), 58-week-old male Wistar rats were selected and randomly divided into the normal group, model group, control group, low-dose group, and high-dose group. The model group and the drug group are given intraperitoneal injections of vitamins, and the model group and the drug group are given a high-fat diet. Rats in the low-dose group and high-dose group are given low-dose and high-dose Dahuang Zhechong pill lavage solution, respectively. Besides, the control group is given simvastatin solution by gavage, and intervention is performed once a day for 12 weeks. Ubiquitin (Ub) protein expression, ubiquitin activase (UBE1), nuclear factor-κB, nuclear inhibitory factor-κB (IκB) gene expression, total cholesterol (TC), triglyceride (TG), low-density lipoprotein cholesterol (LDL-C), and serum tumor necrosis factor-α (TNF-α) are compared. The experimental result shows that Dahuang Zhechong pills can reduce inflammation and prevent and treat AS by blocking the activation of the UPP/NF-κB signaling pathway and can be used as a proteasome inhibitor in the clinical treatment of AS.Entities:
Mesh:
Substances:
Year: 2022 PMID: 36134116 PMCID: PMC9482499 DOI: 10.1155/2022/6056829
Source DB: PubMed Journal: Contrast Media Mol Imaging ISSN: 1555-4309 Impact factor: 3.009
Figure 1H&E staining results of aorta of rats in normal group and model set (×400). (a) Model group. (b) Normal group.
Figure 2H&E staining results of rat aorta in the administration group (×400). (a) Matched group. (b) LDG. (c) HDG.
Changes of blood lipid indexes in each group.
| Group | TC (mmol/L) | TG (mmol/L) | LDL-C (mmol/L) |
|---|---|---|---|
| Normal group | 2.34 ± 0.19 | 0.90 ± 0.14 | 0.60 ± 0.09 |
| Model set | 11.22 ± 3.21 | 2.21 ± 0.49 | 2.56 ± 0.67 |
| Matched group | 6.34 ± 2.09 | 1.12 ± 0.21 | 1.53 ± 0.31 |
| LDG | 10.92 ± 3.20 | 2.18 ± 0.47 | 2.53 ± 0.63 |
| HDG | 6.28 ± 2.07 | 1.09 ± 0.19 | 1.50 ± 0.29 |
Changes of TNF-α in each group.
| Group | TNF- |
|---|---|
| Normal group | 1.41 ± 0.17 |
| Model set | 2.31 ± 0.28 |
| Matched group | 1.75 ± 0.20 |
| LDG | 2.28 ± 0.26 |
| HDG | 1.72 ± 0.19 |
Changes of Ub protein expression in each group.
| Group | The OD values for the expression of the Ub protein |
|---|---|
| Normal group | 0.41 ± 0.07 |
| Model set | 0.71 ± 0.18 |
| Matched group | 0.55 ± 0.14 |
| LDG | 0.68 ± 0.16 |
| HDG | 0.52 ± 0.13 |
mRNA expression of UBE1, NF-κB, and IκB in each group.
| Group | UBE1 mRNA | NF- | I |
|---|---|---|---|
| Normal group | 0.31 ± 0.04 | 0.39 ± 0.02 | 0.52 ± 0.05 |
| Model set | 0.61 ± 0.10 | 0.64 ± 0.09 | 0.26 ± 0.02 |
| Matched group | 0.42 ± 0.07 | 0.45 ± 0.04 | 0.36 ± 0.03 |
| LDG | 0.57 ± 0.09 | 0.62 ± 0.07 | 0.28 ± 0.03 |
| HDG | 0.40 ± 0.06 | 0.42 ± 0.05 | 0.40 ± 0.03 |